Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tscan Therapeutics, Inc.

2.48
0.0000
Post-market: 2.45-0.0300-1.21%19:38 EDT
Volume:711.92K
Turnover:1.72M
Market Cap:140.74M
PE:-1.03
High:2.57
Open:2.48
Low:2.28
Close:2.48
52wk High:6.23
52wk Low:1.02
Shares:56.75M
Float Shares:44.03M
Volume Ratio:0.94
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4102
EPS(LYR):-2.2530
ROE:-63.33%
ROA:-26.77%
PB:0.80
PE(LYR):-1.10

Loading ...

TScan Therapeutics Inc. Files Initial Beneficial Ownership Statement for Principal Accounting Officer Dworak Leiden

Reuters
·
Aug 23

TScan Therapeutics Appoints Leiden Dworak as Principal Accounting Officer, Jason Amello Continues as CFO

Reuters
·
Aug 21

BRIEF-TScan Therapeutics Q2 Net Income USD -36.952 Million

Reuters
·
Aug 12

TScan Therapeutics Q2 2025 Results: Revenue Surges to $3.1M, Net Loss Widens to $37M

Reuters
·
Aug 12

TScan Therapeutics Inc - to Dose First Solid Tumor Patients With Multiplex Tcr-T in Q3 2025

THOMSON REUTERS
·
Aug 12

TScan Therapeutics Q2 Basic EPS USD -0.28

THOMSON REUTERS
·
Aug 12

TScan Therapeutics Q2 Collaboration and License Revenue USD 3.076 Million

THOMSON REUTERS
·
Aug 12

TScan Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
Aug 08

TScan Therapeutics Inc. Conducted Annual Stockholder Meeting

Reuters
·
Jul 02

TScan Therapeutics to Present at Jefferies Global Healthcare Conference

Reuters
·
May 28

Lynx1 Capital Management LP Reports Acquisition of Common Shares of TScan Therapeutics Inc

Reuters
·
May 22

TScan Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

TScan Therapeutics Q1 Net Income USD -34.127 Million

Reuters
·
May 06

TScan Therapeutics Q1 EPS $(0.26) Beats $(0.29) Estimate, Sales $2.17M Beat $1.10M Estimate

Benzinga
·
May 06

TScan Therapeutics Inc. to Present at American Society of Gene and Cell Therapy Annual Meeting

Reuters
·
Apr 29

Press Release: TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

Dow Jones
·
Apr 29